---
layout: page
title: MPEP Patent Appilcation Manual
image:
  feature: /wide/transmission-patent-gray-blueprint.jpg
---
   <head>
      <title>2403-</title>
      <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
</head>
      <li><a href="index.html">Manual of Patent Examining Procedure</a></li>
      <li><a href="mpep-2400.html"><span>Chapter 2400</span></a></li>
      <li><span>Section 2403</span></li>  </ul>
      <div id="yui-main">
         <div class="yui-b">
            <div class="yui-g">  <div xmlns:bf="http://www.uspto.gov/bf" id="article">
               <div>
                  <div xmlns="" class="Section" id="d0e240680">
                     <h1 class="page-title">2403
                          
                        Deposit of Biological Material  [R-08.2012]
                     </h1>
                     <div id="d0e240684" class="CFR">
                        <h4 class="CFR"><i>37 C.F.R. 1.801  
                              
                              
                              
                              Biological material.</i></h4>
                        <p id="d0e240688">For the purposes of these
                           regulations pertaining to the deposit of biological material for purposes of patents for
                           inventions under <b><a href="mpep-9015-appx-l.html#d0e302376">35 U.S.C. 101</a></b>, the term biological
                           material shall include material that is capable of self-replication either directly or
                           indirectly. Representative examples include bacteria, fungi including yeast, algae,
                           protozoa, eukaryotic cells, cell lines, hybridomas, plasmids, viruses, plant tissue
                           cells, lichens and seeds. Viruses, vectors, cell organelles and other non-living
                           material existing in and reproducible from a living cell may be deposited by deposit of
                           the host cell capable of reproducing the non-living material.
                        </p>
                     </div>
                     <p id="d0e240694"><b><a href="mpep-9020-appx-r.html#d0e333189">37 CFR
                              1.801</a></b> indicates that the rules pertaining to deposits for purposes of
                        patents for inventions under <b><a href="mpep-9015-appx-l.html#d0e302376">35 U.S.C. 101</a></b> are intended to relate to
                        biological material. For the purposes of these rules, the term “biological material” is
                        defined in terms of a non-exhaustive list of representative materials which can be
                        deposited in accordance with the procedures defined in these rules. These rules are
                        intended to address procedural matters in the deposit of biological material for patent
                        purposes. They are not designed to decide substantive issues such as whether a deposit of a
                        particular organism or material would be recognized or necessary for the purposes of
                        satisfying the statutory requirements for patentability under <b><a href="mpep-9015-appx-l.html#d0e302824">35 U.S.C.
                              112</a></b>. Although the issue of the need to make a deposit of biological
                        material typically arises under the enablement requirement of the first paragraph of
                        <b><a href="mpep-9015-appx-l.html#d0e302824">35 U.S.C. 112</a></b>, the issue could also arise under the description
                        requirement (<b><a href="mpep-9015-appx-l.html#d0e302824">35 U.S.C. 112</a></b>, first paragraph), best
                        mode requirement (<b><a href="mpep-9015-appx-l.html#d0e302824">35 U.S.C. 112</a></b>, first paragraph) or the
                        requirements of the second paragraph of <b><a href="mpep-9015-appx-l.html#d0e302824">35 U.S.C. 112</a></b> with
                        respect to the claims. 
                     </p>
                     <p id="d0e240717"><b><a href="mpep-9020-appx-r.html#d0e333189">37 CFR
                              1.801</a></b> does not attempt to identify what biological material either
                        needs to be or may be deposited to comply with the requirements of <b><a href="mpep-9015-appx-l.html#d0e302824">35 U.S.C.
                              112</a></b>. For the most part, this issue must be addressed on a
                        case-by-case basis. Thus, while the Office does not currently contemplate that there would
                        be any situations where a material that is not capable of self-replication either directly
                        or indirectly would be acceptable as a deposit, an applicant is clearly not precluded by
                        these rules from attempting to show in any given application why the deposit of such a
                        material should be acceptable to satisfy the requirements of <b><a href="mpep-9015-appx-l.html#d0e302824">35 U.S.C.
                              112</a></b>.
                     </p>
                     <div class="Section">
                        <h1 class="page-title" id="d0e240728">2403.01
                             Material Capable of Self- Replication [R-08.2012]
                        </h1>
                        <p id="d0e240732">Biological material includes
                           material that is capable of self-replication either directly or indirectly. Direct
                           self-replication includes those situations where the biological material reproduces by
                           itself. Representative examples of materials capable of self-replication are defined in
                           the rule. Indirect self-replication is meant to include those situations where the
                           biological material is only capable of replication when another self-replicating
                           biological material is present. Self-replication after insertion in a host is one
                           example of indirect self-replication. Examples of indirect replicating biological
                           materials include viruses, phages, plasmids, symbionts, and replication defective cells.
                           The list of representative examples of each type of replicating material includes
                           viruses to demonstrate that the two lists in the rule are not intended to be mutually
                           exclusive.
                        </p>
                     </div>
                     <div class="Section">
                        <h1 class="page-title" id="d0e240735">2403.02
                             Plant Material  [R-08.2012]
                        </h1>
                        <p id="d0e240739">Although plant material is included
                           within the scope of the definition of biological material for purposes of patents for
                           plant inventions under <b><a href="mpep-9015-appx-l.html#d0e302376">35 U.S.C. 101</a></b>, the rules on deposits
                           are not applicable to applications filed under the Plant Patent Act (<b><a href="mpep-9015-appx-l.html#d0e304416">35 U.S.C.
                                 161</a></b>-<b><a href="mpep-9015-appx-l.html#d0e304454">164</a></b>). The Office is of the view that
                           a deposit is not required under the present provisions of <b><a href="mpep-9015-appx-l.html#d0e304430">35 U.S.C.
                                 162</a></b>. Thus, a deposit is not necessary for the grant of a plant
                           patent under the provisions of <b><a href="mpep-9015-appx-l.html#d0e304416">35 U.S.C. 161</a></b>-<b><a href="mpep-9015-appx-l.html#d0e304454">164</a></b>. As with other biological material deposited for purposes of
                           patents for inventions under <b><a href="mpep-9015-appx-l.html#d0e302376">35 U.S.C. 101</a></b>, the deposit of plant
                           material together with the written specification must enable those skilled in the art to
                           make and use the claimed invention, in accordance with the requirements of
                           <b><a href="mpep-9015-appx-l.html#d0e302824">35
                                 U.S.C. 112</a></b>. 
                        </p>
                        <p id="d0e240766">As with some types of reproducible
                           biological material, seeds can be reproduced only after a growing season which may be
                           relatively long. Although the rules do not specify a specific number of seeds to be
                           deposited to meet the requirements of these rules, the Office will consider 2500 to be a
                           minimum number in the normal case, but will give an applicant the opportunity to provide
                           justification why a lesser number would be suitable under the circumstances of a
                           particular case. The Department of Agriculture requires a deposit of 2500 seeds for the
                           grant of a Plant Variety Protection Certificate under the Plant Variety Protection Act
                           (7 U.S.C. 2321 <i>et seq</i>.). As the reproduction of
                           seeds will often take a substantial period of time, the Office will require, at a
                           minimum for the grant of a patent, a number of seeds that is likely to satisfy demand
                           for samples once the patent is granted. In one instance, the Office accepted a deposit
                           of 600 seeds coupled with an undertaking to deposit 1900 more seeds with due diligence.
                           The particular situation involved a “seedless” vegetable with very few seeds per
                           “fruit;” about two growing seasons were required to provide the additional 1900
                           seeds.
                        </p>
                     </div>
                     <p align="right"><a href="#top">[top]</a></p>
                  </div>
               </div>
               <div>
                  <h1 class="page-title"> </h1>
               </div>  </div>
            </div>
         </div>
      </div>
      <div class="yui-b">
         <div id="aside">  <div id="rdms-sub-nav-container" xmlns:bf="http://www.uspto.gov/bf">
            <ul id="sub-nav">
               <li xmlns=""><a href="s2401.html">2401-Introduction</a></li>
               <li xmlns=""><a href="s2402.html">2402-The Deposit Rules</a></li>
               <li xmlns=""><a href="s2403.html">2403-Deposit of Biological Material</a><ul>
                     <li><a href="s2403.html#d0e240728">2403.01-Material Capable of Self- Replication</a></li>
                     <li><a href="s2403.html#d0e240735">2403.02-Plant Material</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2404.html">2404-Need or Opportunity to Make a Deposit</a><ul>
                     <li><a href="s2404.html#d0e240816">2404.01-Biological Material That Is Known and Readily Available to the Public</a></li>
                     <li><a href="s2404.html#d0e240930">2404.02-Biological Material That Can Be Made or Isolated Without Undue Experimentation</a></li>
                     <li><a href="s2404.html#d0e240946">2404.03-Reference to a Deposit in the Specification</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2405.html">2405-Acceptable Depository</a></li>
               <li xmlns=""><a href="s2406.html">2406-Time of Making an Original Deposit</a><ul>
                     <li><a href="s2406.html#d0e241742">2406.01-Description in Application Specification</a></li>
                     <li><a href="s2406.html#d0e241769">2406.02-Deposit After Filing Date - Corroboration</a></li>
                     <li><a href="s2406.html#d0e241779">2406.03-Possible Loss of U.S. Filing Date in Other Countries</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2407.html">2407-Replacement or Supplement of Deposit</a><ul>
                     <li><a href="s2407.html#d0e241898">2407.01-In a Pending Application</a></li>
                     <li><a href="s2407.html#d0e241922">2407.02-After a Patent Has Issued</a></li>
                     <li><a href="s2407.html#d0e241949">2407.03-Failure to Replace</a></li>
                     <li><a href="s2407.html#d0e241964">2407.04-Treatment of Replacement</a></li>
                     <li><a href="s2407.html#d0e241982">2407.05-Exemption From Replacement</a></li>
                     <li><a href="s2407.html#d0e241992">2407.06-Replacement May Not Be Recognized</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2408.html">2408-Term of Deposit</a></li>
               <li xmlns=""><a href="s2409.html">2409-Viability of Deposit</a></li>
               <li xmlns=""><a href="s2410.html">2410-Furnishing of Samples</a><ul>
                     <li><a href="s2410.html#d0e242157">2410.01-Conditions of Deposit</a></li>
                     <li><a href="s2410.html#d0e242206">2410.02-Certification of Statement of Availability of Deposit</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2411.html">2411-Examination Procedures</a><ul>
                     <li><a href="s2411.html#d0e242312">2411.01-Rejections Based on Deposit Issue</a></li>
                     <li><a href="s2411.html#d0e242401">2411.02-Replies to Rejections Based on Deposit Issue</a></li>
                     <li><a href="s2411.html#d0e242424">2411.03-Application in Condition for Allowance Except for Deposit</a></li>
                     <li><a href="s2411.html#d0e242459">2411.04-After a Patent Has Been Granted</a></li>
                     <li><a href="s2411.html#d0e242505">2411.05-Content of Application with Respect to Deposited Material</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2412-2419.html">2412-2419-[Reserved]</a></li>
               <li xmlns=""><a href="s2420.html">2420-The Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures - the Sequence
                     Rules</a></li>
               <li xmlns=""><a href="s2421.html">2421-Overview of the Sequence Rules</a><ul>
                     <li><a href="s2421.html#d0e242552">2421.01-Applications Affected</a></li>
                     <li><a href="s2421.html#d0e242568">2421.02-Summary of the Requirements of the Sequence Rules</a></li>
                     <li><a href="s2421.html#d0e242594">2421.03-Notification of a Failure to Comply</a></li>
                     <li><a href="s2421.html#d0e242622">2421.04-Future Changes to the Sequence Rules</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2422.html">2422-Nucleotide and/or Amino Acid Sequence Disclosures in Patent Applications</a><ul>
                     <li><a href="s2422.html#d0e245121">2422.01-Definitions of Nucleotide and/or Amino Acids for Purpose of Sequence Rules</a></li>
                     <li><a href="s2422.html#d0e245175">2422.02-The Requirement for Exclusive Conformance; Sequences Presented in Drawing Figures</a></li>
                     <li><a href="s2422.html#d0e245191">2422.03-The Requirements for a Sequence Listing and Sequence Identifiers; Sequences Embedded in Application Text; Variants of a Presented
                           Sequence</a></li>
                     <li><a href="s2422.html#d0e245299">2422.04-The Requirement for a Computer Readable Copy of the Official Copy of the Sequence Listing</a></li>
                     <li><a href="s2422.html#d0e245330">2422.05-Reference to Previously Filed Identical Computer Readable Form; Continuing or Derivative Applications; Request for Transfer
                           of Computer Readable Form</a></li>
                     <li><a href="s2422.html#d0e245358">2422.06-Requirement for Statement Regarding Content of Official and Computer Readable Copies of Sequence Listing</a></li>
                     <li><a href="s2422.html#d0e245376">2422.07-Requirements for Compliance, Statements Regarding New Matter, and Sanctions for Failure to Comply</a></li>
                     <li><a href="s2422.html#d0e245454">2422.08-Presumptions Regarding Compliance</a></li>
                     <li><a href="s2422.html#d0e245470">2422.09-Box Sequence; Hand Delivery of Sequence Listings and Computer Readable Forms</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2423.html">2423-Symbols and Format To Be Used for Nucleotide and/or Amino Acid Sequence Data</a><ul>
                     <li><a href="s2423.html#d0e245579">2423.01-Format and Symbols To Be Used in Sequence Listings</a></li>
                     <li><a href="s2423.html#d0e245618">2423.02-Depiction of Coding Regions</a></li>
                     <li><a href="s2423.html#d0e245637">2423.03-Presentation and Enumeration of Sequences</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2424.html">2424-Requirements for Nucleotide and/or Amino Acid Sequences as Part of the Application Papers</a><ul>
                     <li><a href="s2424.html#d0e246252">2424.01-Informational Requirements for the Sequence Listing</a></li>
                     <li><a href="s2424.html#d0e246289">2424.02-Sequence Listing Numeric Identifiers</a></li>
                     <li><a href="s2424.html#d0e246838">2424.03-Additional Miscellaneous Requirements</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2425.html">2425-Form and Format for Nucleotide and/or Amino Acid Sequence Submissions in Computer Readable Form</a></li>
               <li xmlns=""><a href="s2426.html">2426-Amendments to or Replacement of Sequence Listing and Computer Readable Copy Thereof</a></li>
               <li xmlns=""><a href="s2427.html">2427-Form Paragraphs and Notice to Comply</a><ul>
                     <li><a href="s2427.html#d0e247062">2427.01-Form Paragraphs</a></li>
                     <li><a href="s2427.html#d0e247506">2427.02-Notice To Comply</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2428.html">2428-Sample Statements</a></li>
               <li xmlns=""><a href="s2429.html">2429-Helpful Hints for Compliance</a></li>
               <li xmlns=""><a href="s2430.html">2430-PatentIn Information; Utilities Programs; Training</a></li>
               <li xmlns=""><a href="s2431.html">2431-Sample Sequence Listing</a></li>
               <li xmlns=""><a href="s2432-2433.html">2432-2433-[Reserved]</a></li>
               <li xmlns=""><a href="s2434.html">2434-Examination of Patent Applications Claiming Large Numbers of Nucleotide Sequences</a></li>
               <li xmlns=""><a href="s2435.html">2435-Publishing of Patents and Patent Application Publications with Lengthy Sequence Listings</a></li>
            </ul>  </div>
         </div>
      </div>  </div>
      

  <div style="text-align:right"> Last Modified: 

     

    03/27/2014 10:10:34 

  </div>

</div>

</div>




<!-- End of footer2.html -->


   </body>
</html>